CA2660962A1 - Nouvelle composition pharmaceutique pour le traitement de la schizophrenie - Google Patents
Nouvelle composition pharmaceutique pour le traitement de la schizophrenie Download PDFInfo
- Publication number
- CA2660962A1 CA2660962A1 CA2660962A CA2660962A CA2660962A1 CA 2660962 A1 CA2660962 A1 CA 2660962A1 CA 2660962 A CA2660962 A CA 2660962A CA 2660962 A CA2660962 A CA 2660962A CA 2660962 A1 CA2660962 A1 CA 2660962A1
- Authority
- CA
- Canada
- Prior art keywords
- lower alkyl
- substituted
- schizophrenia
- pharmaceutical composition
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2660962A CA2660962A1 (fr) | 2009-03-31 | 2009-03-31 | Nouvelle composition pharmaceutique pour le traitement de la schizophrenie |
KR1020117025603A KR20120004488A (ko) | 2009-03-31 | 2010-03-30 | 정신분열증의 치료를 위한 2,4,6-트리아미노-1,3,5-트리아진 유도체를 포함하는 조성물 |
EP10719652A EP2413940A1 (fr) | 2009-03-31 | 2010-03-30 | Compositions comprenant des derives de 2, 4, 6-triamino-1, 3, 5-triazine pour le traitement de la schizophrenie |
PCT/JP2010/056144 WO2010114163A1 (fr) | 2009-03-31 | 2010-03-30 | Compositions comprenant des derives de 2, 4, 6-triamino-1, 3, 5-triazine pour le traitement de la schizophrenie |
CN2010800150329A CN102378630A (zh) | 2009-03-31 | 2010-03-30 | 用于治疗精神分裂症的包含2,4,6-三氨基-1,3,5-三嗪衍生物的组合物 |
JP2011541012A JP2012521963A (ja) | 2009-03-31 | 2010-03-30 | 新規統合失調症治療用医薬組成物 |
TW099109850A TW201035081A (en) | 2009-03-31 | 2010-03-31 | Novel pharmaceutical composition for treatment of schizophrenia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2660962A CA2660962A1 (fr) | 2009-03-31 | 2009-03-31 | Nouvelle composition pharmaceutique pour le traitement de la schizophrenie |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2660962A1 true CA2660962A1 (fr) | 2010-09-30 |
Family
ID=42269730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2660962A Abandoned CA2660962A1 (fr) | 2009-03-31 | 2009-03-31 | Nouvelle composition pharmaceutique pour le traitement de la schizophrenie |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2413940A1 (fr) |
JP (1) | JP2012521963A (fr) |
KR (1) | KR20120004488A (fr) |
CN (1) | CN102378630A (fr) |
CA (1) | CA2660962A1 (fr) |
TW (1) | TW201035081A (fr) |
WO (1) | WO2010114163A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103351348A (zh) * | 2013-07-15 | 2013-10-16 | 黄河三角洲京博化工研究院有限公司 | 一种2-甲胺基嘧啶盐酸盐的合成方法 |
KR200492485Y1 (ko) | 2016-02-16 | 2020-10-23 | 주식회사 마르시끄 | 일회용 마스카라 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1982799A (en) | 1998-01-23 | 1999-08-09 | Yamanouchi Pharmaceutical Co., Ltd. | Novel potassium channel protein |
KR100947185B1 (ko) | 2000-12-21 | 2010-03-15 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제 억제제로서 유용한 피라졸 화합물 및 이를 포함하는 조성물 |
US7375222B2 (en) * | 2002-02-05 | 2008-05-20 | Astellas Pharma Inc. | 2,4,6-Triamino-1,3,5-triazine derivative |
JP2010524434A (ja) * | 2007-03-26 | 2010-07-22 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | Kcnh2の統合失調症関連アイソフォームおよび抗精神病薬の開発 |
-
2009
- 2009-03-31 CA CA2660962A patent/CA2660962A1/fr not_active Abandoned
-
2010
- 2010-03-30 CN CN2010800150329A patent/CN102378630A/zh active Pending
- 2010-03-30 JP JP2011541012A patent/JP2012521963A/ja not_active Withdrawn
- 2010-03-30 WO PCT/JP2010/056144 patent/WO2010114163A1/fr active Application Filing
- 2010-03-30 KR KR1020117025603A patent/KR20120004488A/ko unknown
- 2010-03-30 EP EP10719652A patent/EP2413940A1/fr not_active Withdrawn
- 2010-03-31 TW TW099109850A patent/TW201035081A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010114163A1 (fr) | 2010-10-07 |
TW201035081A (en) | 2010-10-01 |
JP2012521963A (ja) | 2012-09-20 |
CN102378630A (zh) | 2012-03-14 |
KR20120004488A (ko) | 2012-01-12 |
EP2413940A1 (fr) | 2012-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1727551B1 (fr) | Composition pharmaceutique comprenant un derive de benzodiazepine et un inhibiteur de la proteine de fusion du virus respiratoire syncytial | |
EP1921077B1 (fr) | Agent de traitement et/ou de prevention des troubles du sommeil | |
CA3112129A1 (fr) | Polytherapies | |
CN104302295B (zh) | 用tor 激酶抑制剂治疗癌症 | |
TW200413374A (en) | Novel adenine derivative and its use | |
EP3077391B1 (fr) | Utilisation de dérivés de benzimidazole-proline | |
EP3570940B1 (fr) | Pridopidine pour utilisation pour traiter le syndrome de l'x fragile | |
CN111788182B (zh) | 毒蕈碱性乙酰胆碱受体m4的拮抗剂 | |
EP2796450B1 (fr) | Dérivés 6-aminopyridine-3-ol ou leurs sels pharmaceutiquement acceptables, et composition pharmaceutique contenant ces dérivés ou ces sels comme principes actifs pour la prévention ou le traitement des maladies provoquées par l'angiogenèse | |
US9540332B2 (en) | Benzimidazole derivatives as selective blockers of persistent sodium current | |
CA3002489A1 (fr) | Derives d'indoline-2-one | |
CA2660962A1 (fr) | Nouvelle composition pharmaceutique pour le traitement de la schizophrenie | |
US20100256152A1 (en) | Novel pharmaceutical composition for treatment of schizophrenia | |
CN107438435A (zh) | 抗‑hcmv组合物和方法 | |
US20130172342A1 (en) | Benzimidazole derivatives as selective blockers of persistent sodium current | |
US20120088772A1 (en) | Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder | |
CN113754580B (zh) | 一种吡啶吗啉类化合物、其制备方法及其应用 | |
AU2009201338A1 (en) | Novel pharmaceutical composition for treatment of schizophrenia | |
BRPI0901286A2 (pt) | nova composição farmacêutica para o tratamento da esquizofrenia | |
CA3101143A1 (fr) | Forme de sel | |
CN112912078B (zh) | 用于治疗雌激素受体阳性乳腺癌的组合疗法 | |
CA2660954A1 (fr) | Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |
Effective date: 20150331 |